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In the early 1990s, an unexpected phenotype—namely,
premature ovarian failure (POF)—was noted among het-
erozygous carriers of the fragile X mutation (Cronister
et al. 1991; Schwartz et al. 1994). Interestingly, only
premutation carriers have been found to have an in-
creased risk for POF (Allingham-Hawkins et al. 1999),
whereas full-mutation carriers and their noncarrier sis-
ters appear to have the same risk seen in the general
population (∼1%). In the scientific community, accep-
tance or recognition of this phenotype, with its unusual
pattern among carriers, was slow to come—as it should
have been—although carriers of the fragile X mutation
did not need to be convinced of the phenotype’s exis-
tence. The primary reason for the slow acceptance was
the lack of understanding of the molecular mechanism.
The FMR1 premutation allele is unmethlyated and there-
fore is thought to be transcribed and translated in a
manner similar to that of those alleles with a normal
number of CGG repeats in the 5′ untranslated region of
the gene. However, recent data have suggested that these
processes may be altered—at least in male premutation
carriers (Tassone et al. 2000).
Only ∼16% of premutation heterozygotes have POF.
An exciting observation that potentially explains the re-
duced penetrance was recently reported by Hundscheid
et al. (2000a). They found that paternally inherited pre-
mutations (PIP) were more likely to give rise to POF
than were maternally inherited premutations (MIP). This
observation motivated other investigators studying the
fragile X mutation to examine their extended pedigrees
for this same imprinting effect. Murray et al. (2000) and
Vianna-Morgante and Costa (2000) report their findings
in this issue of the Journal. Although both groups note
the rigorous design and implementation of the study of
Hundscheid et al., neither group was able to confirm the
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parent-of-origin effect or to account for the differing
results. All three groups used the same definition of POF,
and all personally interviewed the subjects. Both Hund-
scheid et al. (2000a) and Murray et al. (2000 [in this
issue]) examined the hormonal profiles of those women
who still had menstrual cycles, for a more precise defi-
nition of ovarian function, and the same two groups
used survival analysis to extract full information from
subjects of age !40 years and from those who had had
nonspontaneous cessation of menses.
All three groups are well known for their study of the
fragile X syndrome and have used their extensive sets
of pedigrees, ascertained through individuals with the
fragile X syndrome, for studies of POF among female
premutation carriers. In the reply by Hundscheid et al.
(2000b [in this issue]) to the letters by Murray et al. and
Vianna-Morgante and Costa, several differences in the
demographics of the female premutation carriers in the
three study populations were identified. These demo-
graphic differences and others are presented in table 1.
Most evident are the differences in the average age of
the female subjects and the structure of the pedigrees
from which they were drawn. The females studied by
Hundscheid et al. (2000a) are older (compare age at
examination and the ratio of the number of females of
age 40 years to the number of those of age !40 years)
and most likely are ascertained from larger pedigrees
with more generations (compare the average number of
female premutation carriers who were ascertained per
pedigree and, as an indicator of the number of gener-
ations studied, the PIP:MIP ratio). The younger age of
the female premutation carriers limits the power to ac-
curately estimate the age at menopause in general. The
difference in age at examination among females with
MIP and those with PIP may also be important. In the
study of Hundscheid et al. (2000a), females with PIP
were older than those with MIP, as indicated by the ratio
of the number of subjects of age 40 years compared
with the number of those of age !40 years (3.41 vs.
1.80). This is not true to the same extent for the other
data sets. Such differences in the amount of available
information for each type of premutation carrier should
be overcome by the use of survival analysis as performed
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Table 1
Comparison of Study Populations
POPULATION IN STUDY BY
Hundscheid et al. (2000a) Murray et al. (2000)a
Vianna-Morgante
and Costa (2000)a
No. premutation carriers interviewed (age) 148 (118 years) 116 (not specified) 113 (25 years)
Median age at examination 50 years Not specified 38 years
No. pedigrees examined (average no. females/pedigree) 55 (2.69) 62 (1.87) Not specified
No. PIP/no. MIP/no. unknown [PIP:MIP] 106/42/not specified [2.52] 51/40/25 [1.27] 32/27/54 [1.19]
No. females 40 years at examination (PIP/MIP) [PIP:MIP] 82/27 [3.03] 12/18 [.67] 15/10 [1.50]
Ratio of no. females 40 years at examination:no. females
!40 years at examination (PIP/MIP) 3.41/1.80 .31/.82 .88/.59
Mean age at menopause, for premutation carriersb 45 years 48 years Not done
% POF among females 40 years (PIP/MIP) 28%/4% 17%/28% 33%/20%
a In this issue of the Journal.
b Estimated using survival analysis.
Figure 1 Example of a potential bias of ascertainment resulting
from reduced fertility of female premutation carriers with POF. Sym-
bols containing dots indicate premutation status; diagonally striped
symbols indicate presence of POF.
by Hundscheid et al. (2000a); however, unanticipated
biases may still exist.
One potential bias that cannot be overcome by sur-
vival analysis is the effect of reduced fitness among fe-
male premutation carriers with POF. Presenting an ex-
treme scenario for illustration purposes (see fig. 1), if
female carriers with POF have reduced fertility at later
reproductive ages (late 20s to 30s) and if there is a pos-
itive association of the risk of POF among mothers and
daughters, then there will be selection against mother-
daughter pairs with POF but not among father-daughter
pairs. If this is true, then the ages of the study cohorts
become important, since the age at reproduction has
increased over the past several decades. The results of
pedigree analyses show that premutation carriers with
POF are not completely infertile; however, no studies
have been done to assess the reduction in fitness among
female premutation carriers with and without POF. To
date, no familial effect of POF has been identified among
families with fragile X syndrome, although the data to
observe such an effect are limited. Thus, although this
example of a potential bias may be exaggerated, it il-
lustrates two important points: (1) the study of POF
among premutation carriers is in its infancy, and (2)
possible biases resulting from retrospective ascertain-
ment of subjects and potential effects of reduced fitness
need to be assessed.
As emphasized by all groups of investigators, there is
a clear need to collect additional data using a rigorous
definition of the phenotype, personal interviews backed
by medical records, an accurate description of the study
population (for comparison purposes), and appropriate
statistical analyses. These data are needed not only to
confirm or refute the potential imprinting effect but also
to identify the factors involved in the reduced penetrance
of POF among female premutation carriers.
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